Medicofarma Biotech Statistics

Total Valuation

WSE:MDB has a market cap or net worth of PLN 33.51 million. The enterprise value is 36.81 million.

Market Cap	33.51M
Enterprise Value	36.81M

Important Dates

The last earnings date was Monday, November 10, 2025.

Earnings Date	Nov 10, 2025
Ex-Dividend Date	n/a

Share Statistics

WSE:MDB has 67.98 million shares outstanding.

Current Share Class	67.98M
Shares Outstanding	67.98M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	10.14M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	119.08
PB Ratio	7.04
P/TBV Ratio	7.13
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-12.05
EV / Sales	130.77
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.82, with a Debt / Equity ratio of 0.70.

Current Ratio	0.82
Quick Ratio	0.82
Debt / Equity	0.70
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-13.70

Financial Efficiency

Return on equity (ROE) is -48.60% and return on invested capital (ROIC) is -23.27%.

Return on Equity (ROE)	-48.60%
Return on Assets (ROA)	-14.59%
Return on Invested Capital (ROIC)	-23.27%
Return on Capital Employed (ROCE)	-37.43%
Revenue Per Employee	46,908
Profits Per Employee	-509,193
Employee Count	20
Asset Turnover	0.02
Inventory Turnover	547.28

Taxes

Income Tax	-22,736
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +26.74% in the last 52 weeks. The beta is 1.07, so WSE:MDB's price volatility has been similar to the market average.

Beta (5Y)	1.07
52-Week Price Change	+26.74%
50-Day Moving Average	0.58
200-Day Moving Average	0.39
Relative Strength Index (RSI)	45.64
Average Volume (20 Days)	26,529

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, WSE:MDB had revenue of PLN 281,446 and -3.06 million in losses. Loss per share was -0.04.

Revenue	281,446
Gross Profit	-1.13M
Operating Income	-3.31M
Pretax Income	-3.08M
Net Income	-3.06M
EBITDA	-1.28M
EBIT	-3.31M
Loss Per Share	-0.04

Full Income Statement

Balance Sheet

The company has 21,435 in cash and 3.31 million in debt, giving a net cash position of -3.29 million or -0.05 per share.

Cash & Cash Equivalents	21,435
Total Debt	3.31M
Net Cash	-3.29M
Net Cash Per Share	-0.05
Equity (Book Value)	4.76M
Book Value Per Share	0.07
Working Capital	-876,050

Full Balance Sheet

Cash Flow

Operating Cash Flow	-1.28M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-1,175.95%
Pretax Margin	-1,093.60%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

WSE:MDB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-9.12%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 8, 2011. It was a reverse split with a ratio of 0.1.

Last Split Date	Nov 8, 2011
Split Type	Reverse
Split Ratio	0.1

Scores

WSE:MDB has an Altman Z-Score of -0.31 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.31
Piotroski F-Score	1